Science
Mechanism of Action
LAVANDULA ANGUSTIFOLIA ANGUSTIFOLIA HERB OIL calms skin by modulating inflammation pathways, reducing redness and discomfort. It inhibits AhR activation, relevant in atopic dermatitis, and displays antioxidant properties by combating free radicals. Its antimicrobial action involves altering bacterial cell membranes and disrupting quorum sensing, effective against various bacteria, yeast, and fungi. Additionally, it may act as a mild tyrosinase inhibitor, contributing to reduced melanin production. Cytotoxicity is proposed to occur via membrane damage.
Research
Clinical Evidence
Medium confidence0.05%
Transparency
Dusting Analysis
While specific antimicrobial efficacy has been observed at concentrations as low as 0.00004%, and certain other benefits lack precise human topical dose-response data, its strong aromatic profile makes it susceptible to being included at sub-effective or solely masking concentrations. Crucially, concentrations exceeding 0.125% demonstrate in vitro cytotoxicity to human skin cells, creating a narrow margin for achieving benefits while ensuring cellular safety. Claims for broad therapeutic benefits without specified, safe effective concentrations might indicate dusting.
The Formula
Formulation
Stability
Lavender essential oil is most stable under acidic to neutral conditions (pH 3.0-7.0), as alkaline environments can degrade its components. Esters can hydrolyze at low pH, while monoterpene hydrocarbons and aldehydes may polymerize. Volatility can compromise label accuracy. Components like linalool and linalyl acetate autoxidize upon air exposure, forming contact allergens.
Conflicts
- Alkaline conditions (pH > 7) due to instability
- Direct undiluted application on skin, requiring dilution with a carrier oil
- Individuals with known allergic reactions to components like linalool or linalyl acetate; patch testing is recommended
- Dry skin types, as it lacks hydrating fatty acids
- Topical use in pregnant/breastfeeding women and children under three years old (precautionary principle)
- Topical application around the breast, due to potential estrogenic and antiandrogenic activity
Safety
Safety Profile
The CIR Expert Panel has considered it for review, but a final assessment with a maximum safe concentration is not established. Sensitizing components like linalool and linalyl acetate necessitate disclosure at concentrations exceeding 0.01% in rinse-off and 0.001% in leave-on products (EC 1223/2009). Concerns include potential as an endocrine disruptor and risk of skin irritation. The FDA recognizes it as GRAS for food but not approved for aromatherapy safety/effectiveness.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While offering potential soothing, antimicrobial, and antioxidant benefits, LAVANDULA ANGUSTIFOLIA ANGUSTIFOLIA HERB OIL carries a 'bad' INCIDecoder rating, moderate irritancy, and cytotoxicity concerns above 0.125%, making its inclusion in precision skincare questionable due to significant safety and formulation challenges.
Related
Similar Ingredients
Finding similar ingredients…